Venous thromboembolism (VTE) is an important cause of vascular morbidity and mortality.
Many risk factors have been identified for venous thrombosis that lead to alterations in blood …

Simple Summary The tissue factor (TF)-factor VIIa complex is the major physiological
initiator of blood coagulation. Tumors express TF and release TF-positive extracellular …

Patients with malignancy are at 4-to 7-fold higher risk of venous thromboembolism (VTE), a
potentially fatal, yet preventable complication. Although general mechanisms of thrombosis …

MicroRNAs (miRNAs) are non-coding RNAs that execute their function by targeted
downregulation of gene expressions. There is growing evidence from epidemiological …

Objective: Electrospinning is a promising technology that provides biodegradable nanofiber
scaffolds for cardiovascular tissue engineering. However, success with these materials has …

Objective Provide in vivo blood clot hardening evolution with ultrasound using supersonic
imaging of shear waves. Methods We conducted a prospective study in flow stasis-induced …

Venous thrombosis (VT) is a prevalent clinical condition with significant adverse sequela or
mortality. Anticoagulation and pharmacologic or pharmacomechanical thrombolytic …

Deep venous thrombosis (DVT) is a significant problem in the health care industry
worldwide. However, the factors and signaling pathways that trigger DVT formation are still …

Venous thrombosis (VT) resolution is a complex process, resembling sterile wound healing.
Infiltrating blood-derived monocyte/macrophages (Mo/MΦs) are essential for the regulation …

Deep vein thrombosis is a life-threatening development of blood clots in deep veins.
Immobility and blood flow stagnancy are typical risk factors indicating that fluid dynamics …